
Schaefer Advertising
Independent
Address
1228 S Adams St
Fort Worth, Texas 76104
Web Address
Year Founded
1995
North American Revenue 2022
$15,265,000
North American Revenue 2021
$12,850,000
Full-time Employees 2022
50
Full-time Employees 2021
37
Number of clients 2022
23
Number of clients 2021
17
Offices
North America
1
Locations
Fort Worth, Texas
Executives & Senior Management
Senior Management
Ken Schaefer
President, Owner
Sara Hull
EVP, Account Strategy & Client Development
Doug Austin
VP, Growth & Innovation
Charlie Howlett
VP, Creative Director
Debbie Carrel
VP Controller
Jake Yarbrough
Managing Director, Healthcare
Agency 100 T-Shirt

Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Payer
Med-Tech
Public Health
Data/Analytics
Digital
New Roles
Roles Added
1
Roles
Catherine Land, Director of Talent & Culture
Client Roster
Alcon - Global IOL
Alcon - Global Medical Affairs
Alcon - Corporate Communications
OptMyCare
Right Now Inventory
ViaLase
Galderma - Aklief
Galderma - Twyneo
Galderma - Oracea
Galderma - Epsolay
Galderma - Tri-Luma
Galderma - GCC
Galderma - Mirvaso
Galderma - Soolantra
Galderma - Cetaphil
Galderma - Epiduo Forte
SIGHT SCIENCES - TearCare
Podimetrics
Argon Medical Devices, Inc.
Argon CPS
Cleaner Plus
Argon Biopsy
Argon Drainage Products
TearLab
University of North Texas Health Science Center
Moncrief Cancer Institute
Texas Health Advent - Texas Health Huguley
Texas Health Advent - Texas Health Mansfield
Eosera
Growth
2022 Growth from Existing Clients
70%
2022 Growth from New Clients
30%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Replenishing new-business pipeline
Shrinking pharma budgets
Further diversification of services
Regulatory concerns
Competition from consultancies and other non-traditional organizations
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Creative Samples


